Doctor profile · Federal record
Dr. Ivan Aksentijevich, M.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Hematology (Internal Medicine) Physician · Medical Oncology Physician · Alexandria, VA
- NPI 1982672937
- Accepts Medicare
- MIPS 89.8 / 100 · 2023
- 40 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
4660 Kenmore Ave Ste 1018
Alexandria, VA 223041306
(571) 483-1800
fax (703) 823-5723 - Mailing address
-
3040 Williams Dr, Suite 100
Fairfax, VA 220314618
Credentials & registration
- NPI registered
- March 2006 — 20 yrs on file
- Profile last updated
- November 11, 2025
- Year of graduation
- 1986 — 40 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Virginia #0101234651
- Medicaid
- VA #1982672937
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1982672937. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
55,695
Distinct HCPCS
10
Medicare allowed
$1,023,672
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 29,250 | 25 | $1 | |
J9271 |
Injection, pembrolizumab, 1 mg | 5,600 | 12 | $54 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 5,220 | 12 | $47 | |
J0897 |
Injection, denosumab, 1 mg | 2,820 | 19 | $23 | |
J1568 |
Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 1,980 | 17 | $42 | |
J9041 |
Injection, bortezomib, 0.1 mg | 1,444 | 11 | $4 | |
36415 |
Insertion of needle into vein for collection of blood sample | 1,090 | 271 | $8 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 1,031 | 251 | $8 | |
80053 |
Blood test, comprehensive group of blood chemicals | 823 | 228 | $10 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 810 | 30 | $0 |
In context: peer comparison
Among 5 peers in Alexandria Hematology & Oncology Physician, average services per provider: 1,103. This provider delivers 50× the peer median.Open Payments
Industry payments received
All-time total
$450
Transactions
17
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $95.21 | |
| Abbvie INC. | 2 | $60.57 | |
| Celgene Corporation | 2 | $55.42 | |
| Alexion Pharmaceuticals, INC. | 2 | $51.91 | |
| Daiichi Sankyo INC. | 2 | $40.76 | |
| AstraZeneca Pharmaceuticals Lp | 1 | $34.20 | |
| Genentech USA, INC. | 1 | $28.99 | |
| Merck Sharp & Dohme LLC | 1 | $24.96 | |
| SpringWorks Therapeutics, INC. | 1 | $23.92 | |
| Puma Biotechnology, INC. | 1 | $20.95 | |
| Pfizer INC. | 1 | $13.27 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
338
Patients
24
Total drug cost
$1,644,914
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Dexamethasone | Generic | 44 | 0 | $810 |
| Lenalidomide | Generic | 37 | 0 | $396,856 |
| Hydroxyurea | Generic | 36 | 12 | $1,507 |
| Eliquis (Apixaban) | Brand | 34 | 0 | $33,110 |
| Acyclovir | Generic | 28 | 0 | $487 |
| Pomalyst (Pomalidomide) | Brand | 22 | 0 | $486,161 |
| Prednisone | Generic | 22 | 0 | $191 |
| Prochlorperazine Maleate | Generic | 21 | 12 | $211 |
| Jakafi (Ruxolitinib Phosphate) | Brand | 18 | 0 | $330,987 |
| Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim) | Brand | 15 | 0 | $148 |
Hospital affiliations
Frequently asked questions
What is Dr. Ivan Aksentijevich's medical specialty?
Dr. Ivan Aksentijevich practices Hematology & Oncology Physician in Alexandria, VA.
Where does Dr. Ivan Aksentijevich practice?
Dr. Ivan Aksentijevich practices at 4660 Kenmore Ave Ste 1018, Alexandria, VA 223041306. Office phone: 5714831800.
What is Dr. Ivan Aksentijevich's NPI?
Dr. Ivan Aksentijevich's National Provider Identifier (NPI) is 1982672937, issued by NPPES.
Does Dr. Ivan Aksentijevich accept Medicare assignment?
Yes. Dr. Ivan Aksentijevich accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Ivan Aksentijevich commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS J9144). Source: CMS Medicare Physician & Other Practitioners file.